Skip to main content

In-vivo detectability index: Development and validation of an automated methodology

Publication ,  Conference
Smith, TB; Solomon, J; Samei, E
Published in: Progress in Biomedical Optics and Imaging - Proceedings of SPIE
January 1, 2017

The purpose of this study was to develop and validate a method to estimate patient-specific detectability indices directly from patients' CT images (i.e., "in vivo"). The method works by automatically extracting noise (NPS) and resolution (MTF) properties from each patient's CT series based on previously validated techniques. Patient images are thresholded into skin-air interfaces to form edge-spread functions, which are further binned, differentiated, and Fourier transformed to form the MTF. The NPS is likewise estimated from uniform areas of the image. These are combined with assumed task functions (reference function: 10 mm disk lesion with contrast of -15 HU) to compute detectability indices for a non-prewhitening matched filter model observer predicting observer performance. The results were compared to those from a previous human detection study on 105 subtle, hypo-attenuating liver lesions, using a two-alternative-forcedchoice (2AFC) method, over 6 dose levels using 16 readers. The in vivo detectability indices estimated for all patient images were compared to binary 2AFC outcomes with a generalized linear mixed-effects statistical model (Probit link function, linear terms only, no interactions, random term for readers). The model showed that the in vivo detectability indices were strongly predictive of 2AFC outcomes (P < 0.05). A linear comparison between the human detection accuracy and model-predicted detection accuracy (for like conditions) resulted in Pearson and Spearman correlations coefficients of 0.86 and 0.87, respectively. These data provide evidence that the in vivo detectability index could potentially be used to automatically estimate and track image quality in a clinical operation.

Duke Scholars

Published In

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

DOI

ISSN

1605-7422

ISBN

9781510607095

Publication Date

January 1, 2017

Volume

10132
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Smith, T. B., Solomon, J., & Samei, E. (2017). In-vivo detectability index: Development and validation of an automated methodology. In Progress in Biomedical Optics and Imaging - Proceedings of SPIE (Vol. 10132). https://doi.org/10.1117/12.2255411
Smith, T. B., J. Solomon, and E. Samei. “In-vivo detectability index: Development and validation of an automated methodology.” In Progress in Biomedical Optics and Imaging - Proceedings of SPIE, Vol. 10132, 2017. https://doi.org/10.1117/12.2255411.
Smith TB, Solomon J, Samei E. In-vivo detectability index: Development and validation of an automated methodology. In: Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2017.
Smith, T. B., et al. “In-vivo detectability index: Development and validation of an automated methodology.” Progress in Biomedical Optics and Imaging - Proceedings of SPIE, vol. 10132, 2017. Scopus, doi:10.1117/12.2255411.
Smith TB, Solomon J, Samei E. In-vivo detectability index: Development and validation of an automated methodology. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2017.

Published In

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

DOI

ISSN

1605-7422

ISBN

9781510607095

Publication Date

January 1, 2017

Volume

10132